Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Phac2g01741 | ATGCCTGTTCTTCTTCTCCTAGTGCTGTTGTGCGCACCCCTCTTAACGTGCGCCGATCGCAGCGCCGTTACTGTTGTGGAGATCCAAGCCTTGACGTCTTTCAAGCTTAACCTTCACGACCCCGTCGGAGCTCTCGACGGTTGGGATCCAACGTCGCCGGCGGCACCCTGCGACTGGCGCGGAGTAGCCTGCACCAATAGCCGAGTCACGGAGTTGCGCCTGCCTCGCCTTCAACTGGGTGGCAGACTCAGTGAGCGTGTCTCCGAGTTGCGCATGTTACGCAAGATAAGTCTTCGTTCCAACAACTTCAACGGAAGCATTCCTTCGTCACTCTCCAAATGCACGCTTTTATGGTCATTGTTCCTTCAGGATAATTCGTTTTCCGGCAACCTTCCGACGGAGATCGCAAACCTCACCGGCCTTAAGATTCTCAACGTCGCGCTAAACCGCCTCTCCGGCAGTATCCCCGGCATTCTCCCTCTCGGCCTCAAAGCCCTCGACCTCTCGTCGAACGCCTTCTCCGGCGCGATTCCGAGCTCCATAGCGAACCTATATCAGCTTCAGTTGATAAACCTGTCGTATAACCATTTTTCCGGCGAGATCCCGGCGAGCCTCGGGGAGCTTCAGCAGCTGCAGTACCTCTGGCTGGACCACAATCTCCTCGGAGGAACGCTTCCTTCGGCGCTCGCAAATTGCTCCGCGCTTCTGCATCTGAGCGTGGAAGGAAACGCGCTTACCGGCGAGATTCCGTCGGCGATTTCAGTGCTCCCGAAACTTCAGGTGATGTCGCTCTCTCAGAATAACTTCACCGGCTCCATTCCAGCTTCCATTTTGTGCAACGGTTCGGTTCACGCGCCGTCGCTGCGGATTGTTCACCTCAGTTTCAACGGGTTCGTTGATTTCGTGGGACCTGGGATGAGCACGTGTATCAGTGTTCTTCAGGTTTTGGATATTCAGCACAATCGCATACGAGGCACGTTCCCGTTGTGGTTGACCAACGTGACCACGTTAACCGTGCTTGATGTGTCGAACAATGCACTTTTTGGGGAGGTTCCGCCTCAAATAGGAAACCTTGTGAAGTTGGAGGTTTTGAAGATGGCTAATAATTCCTTCACCGGTACCATTCCGGTAGAACTGAAGAAATGTGGGTTCCTAAGTGTCGTTGACTTTGAAGGCAACGAGTTTGGCGGAGAAGTTCCTTCGTTTTTGGGTGATGTGACGGGGCTGAGGGTGCTATCTCTCGGTGGGAACCACTTCTCTGGTTCTGTTCCGGTGAGTTTTGGAAACCTTTCTTTTCTTGAAATGTTGAGTTTGAGAGGTAACAGGTTGAATGGAAGTATGCCTGAGATGATAATGAGATTGAACAATTTGACGATACTGGATCTTAGTGGAAACAAATTTACGGGTCAAGTTTATGCGAGTATTGGGAATTTGAATAAGTTGATGGTTCTCAATCTTAGTGGCAATGGCTTCTCTGGAAAAATTCCTTCTAGTTTGGGGAATCTTTTTAAGCTAACTACGCTTGACTTGAGCAAACAGAATCTTTCTGGAGAGTTACCGCTTGAGCTCTCGGGATTGCCCAGTTTGCAAGTTGTTGCACTGCAGGAAAACAAGTTATCTGGTGATGTGCCTGAAGGGTTTAGCAGTTTGACGAGTTTGCAGTATGTTAATCTCAGTTCTAATGCCTTTTCCGGGAATATTCCTGAAAATTATGGCTTTCTTCGTTCCTTGCTTGTTCTTTCGTTGTCTGATAATGACATTACAGGAGCAATCCCTTCGGAAATTGGAAACTGCTCTGGTATTGAAATTCTTGAGCTTGGATCAAACTCTCTGGCAGGTAGCATTCCTGCTGATCTCTCTCGTCTCACCCTTTTGAGAATGCTTGATTTGAGTGGAAACAATTTAACTGGGGACGTGCCTGCGGAAATCTCCAAATGCTCGGGGCTAACCACTTTGCTGGTGGATCACAACCGTCTTTCCGGGGATATTCCTGGGTCCTTGTGGAATCTACCAAACCTGACAATGCTAGATCTCTCTGCTAACAACTTGAGTGGGGAAATTCCAAGCAATCTTTCTATGATTCCCAGTCTAGTGTTCTTAAATGTCTCGGGAAATAACTTGGACGGTGAGATACCACCAACATTGGGATCTCGGTTCAGTAACCCCGATGTATTCGCAGATAATCCAGGTTTATGTGGGAAGCCATTGGATACGAAATGCGAAGATATAGATAATGGTAAGGACAGAAAGAGGATGATTGTGCTTGTGGTTGTCGTTGCTTGTGGAGCTTTTGTACTGGTTTTGTTTTGCTGCTTCTACGTGTTCAGTCTACTGAGATGGCGTAAAAGACTGAAACAGGGAGTATCGGGTGAAAAGAAAAAGAGTCCCGCCAGAGCCAGTTCTGGAACAAGTGGAGGTCGTAGCAGCAGCACTGAGAGTGGGGGACCAAAACTAGTGATGTTCAACACCAAAGTTACACTTGCTGAGACCATTGAAGCAACAAGACAATTTGACGAAGAGAACGTGCTGAGCAGAACAAGGTATGGATTAGTGTTCAAAGCCTGTTACAACGATGGAATGGTCCTTTCCATTCGCAGGCTCCAAGATGGATCATTGGATGAAAACATGTTTAGAAAAGAAGCCGAATCACTAGGCAAAGTGAAGCACCGAAATTTAATAGTTCTGAGAGGTTACTATGCTGGGCCACCTGACATGAGACTCCTAGTATACGATTACATGCCTAATGGAAACCTCGCAACCCTCCTCCAAGAAGCTTCTCACCAAGATGGCCACGTTCTAAATTGGCCAATGCGACACCTCATTGCACTGGGCATTGCCCGTGGTTTAGCCTTCCTACACCAATCCTCAATGGTTCACGGCACCGTTAAACCACAAAATGTCCTATTCGATGCAGATTTCGAAGCCCATTTATCAGATTTCGGGTTAGAAAAGTTAACAATAGCCACGACCCCAGGCGAAGCCTCAACTTCAGCATCCGTTGGCGCATTGGGTTACGTTTCTCCAGAAGCAGTCTTAACCGGGGAAGCCACAAAGGAGAGTGATGTTTACAGCTTTGGCATTGTGTTGTTGGAACTGCTGACTGGAAAACGACCCGTCATGTTCACCCAGGACGAAGACATAGTGAAGTGGGTAAAAAAACAACTGCAAAGGGGTCAAATAACAGAGCTATTAGAACCGGGTTTGCTTGAGTTGGACCCTGAATCATCAGAGTGGGAAGAGTTTTTACTGGGTGTAAAAGTTGGGTTACTTTGCACAGCACCCGACCCTCTTGATCGACCAACCATGTCTGACATTGTTTTCATGCTCGAAGGCTGCCGAGTTGGTCCTGATATCCCATCCTCTGCAGATCCCACCTCCCAACCTTCTCCGGTGTAA | 3396 | 0.4829 | MPVLLLLVLLCAPLLTCADRSAVTVVEIQALTSFKLNLHDPVGALDGWDPTSPAAPCDWRGVACTNSRVTELRLPRLQLGGRLSERVSELRMLRKISLRSNNFNGSIPSSLSKCTLLWSLFLQDNSFSGNLPTEIANLTGLKILNVALNRLSGSIPGILPLGLKALDLSSNAFSGAIPSSIANLYQLQLINLSYNHFSGEIPASLGELQQLQYLWLDHNLLGGTLPSALANCSALLHLSVEGNALTGEIPSAISVLPKLQVMSLSQNNFTGSIPASILCNGSVHAPSLRIVHLSFNGFVDFVGPGMSTCISVLQVLDIQHNRIRGTFPLWLTNVTTLTVLDVSNNALFGEVPPQIGNLVKLEVLKMANNSFTGTIPVELKKCGFLSVVDFEGNEFGGEVPSFLGDVTGLRVLSLGGNHFSGSVPVSFGNLSFLEMLSLRGNRLNGSMPEMIMRLNNLTILDLSGNKFTGQVYASIGNLNKLMVLNLSGNGFSGKIPSSLGNLFKLTTLDLSKQNLSGELPLELSGLPSLQVVALQENKLSGDVPEGFSSLTSLQYVNLSSNAFSGNIPENYGFLRSLLVLSLSDNDITGAIPSEIGNCSGIEILELGSNSLAGSIPADLSRLTLLRMLDLSGNNLTGDVPAEISKCSGLTTLLVDHNRLSGDIPGSLWNLPNLTMLDLSANNLSGEIPSNLSMIPSLVFLNVSGNNLDGEIPPTLGSRFSNPDVFADNPGLCGKPLDTKCEDIDNGKDRKRMIVLVVVVACGAFVLVLFCCFYVFSLLRWRKRLKQGVSGEKKKSPARASSGTSGGRSSSTESGGPKLVMFNTKVTLAETIEATRQFDEENVLSRTRYGLVFKACYNDGMVLSIRRLQDGSLDENMFRKEAESLGKVKHRNLIVLRGYYAGPPDMRLLVYDYMPNGNLATLLQEASHQDGHVLNWPMRHLIALGIARGLAFLHQSSMVHGTVKPQNVLFDADFEAHLSDFGLEKLTIATTPGEASTSASVGALGYVSPEAVLTGEATKESDVYSFGIVLLELLTGKRPVMFTQDEDIVKWVKKQLQRGQITELLEPGLLELDPESSEWEEFLLGVKVGLLCTAPDPLDRPTMSDIVFMLEGCRVGPDIPSSADPTSQPSPV* | 1132 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Phac2g01741 | 1131 | SUPERFAMILY | RNI-like | 399 | 722 | - | - | |
Phac2g01741 | 1131 | Pfam | Leucine rich repeat | 163 | 221 | IPR001611 | GO:0005515 | |
Phac2g01741 | 1131 | Pfam | Leucine rich repeat | 408 | 467 | IPR001611 | GO:0005515 | |
Phac2g01741 | 1131 | Pfam | Leucine rich repeat | 576 | 635 | IPR001611 | GO:0005515 | |
Phac2g01741 | 1131 | Pfam | Leucine rich repeat | 648 | 707 | IPR001611 | GO:0005515 | |
Phac2g01741 | 1131 | Pfam | Leucine rich repeat N-terminal domain | 27 | 64 | IPR013210 | - | |
Phac2g01741 | 1131 | Gene3D | Ribonuclease Inhibitor | 160 | 248 | IPR032675 | - | |
Phac2g01741 | 1131 | MobiDBLite | consensus disorder prediction | 789 | 817 | - | - | |
Phac2g01741 | 1131 | FunFam | Leucine-rich repeat receptor-like protein kinase PXL1 | 162 | 253 | - | - | |
Phac2g01741 | 1131 | ProSiteProfiles | Protein kinase domain profile. | 837 | 1118 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac2g01741 | 1131 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 800 | 912 | - | - | |
Phac2g01741 | 1131 | SMART | LRR_sd22_2 | 670 | 693 | - | - | |
Phac2g01741 | 1131 | SMART | LRR_sd22_2 | 622 | 651 | - | - | |
Phac2g01741 | 1131 | SMART | LRR_sd22_2 | 334 | 360 | - | - | |
Phac2g01741 | 1131 | SMART | LRR_sd22_2 | 208 | 234 | - | - | |
Phac2g01741 | 1131 | SMART | LRR_sd22_2 | 454 | 480 | - | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 622 | 646 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 256 | 280 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 334 | 358 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 670 | 701 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 138 | 161 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 478 | 502 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 406 | 429 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 526 | 549 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 430 | 453 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 454 | 477 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 208 | 232 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 90 | 114 | IPR003591 | - | |
Phac2g01741 | 1131 | SMART | LRR_typ_2 | 574 | 598 | IPR003591 | - | |
Phac2g01741 | 1131 | FunFam | LRR receptor-like serine/threonine-protein kinase RPK2 | 913 | 1117 | - | - | |
Phac2g01741 | 1131 | Pfam | Protein kinase domain | 847 | 1105 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Phac2g01741 | 1131 | SUPERFAMILY | Outer arm dynein light chain 1 | 68 | 198 | - | - | |
Phac2g01741 | 1131 | SUPERFAMILY | L domain-like | 163 | 509 | - | - | |
Phac2g01741 | 1131 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 621 | 740 | - | - | |
Phac2g01741 | 1131 | Gene3D | Transferase(Phosphotransferase) domain 1 | 913 | 1117 | - | - | |
Phac2g01741 | 1131 | FunFam | Uncharacterized protein | 256 | 472 | - | - | |
Phac2g01741 | 1131 | SUPERFAMILY | Protein kinase-like (PK-like) | 817 | 1119 | IPR011009 | - | |
Phac2g01741 | 1131 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 473 | 567 | - | - | |
Phac2g01741 | 1131 | Gene3D | Ribonuclease Inhibitor | 453 | 743 | IPR032675 | - | |
Phac2g01741 | 1131 | Pfam | Leucine Rich Repeat | 480 | 502 | IPR001611 | GO:0005515 | |
Phac2g01741 | 1131 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 403 | 1111 | - | - | |
Phac2g01741 | 1131 | FunFam | Nuclear pore complex protein NUP107 | 24 | 161 | - | - | |
Phac2g01741 | 1131 | Gene3D | Ribonuclease Inhibitor | 350 | 451 | IPR032675 | - | |
Phac2g01741 | 1131 | Gene3D | Ribonuclease Inhibitor | 249 | 349 | IPR032675 | - | |
Phac2g01741 | 1131 | Gene3D | Ribonuclease Inhibitor | 25 | 159 | IPR032675 | - | |
Phac2g01741 | 1131 | PRINTS | Leucine-rich repeat signature | 625 | 638 | - | - | |
Phac2g01741 | 1131 | PRINTS | Leucine-rich repeat signature | 670 | 683 | - | - | |
Phac2g01741 | 1131 | Gene3D | Phosphorylase Kinase; domain 1 | 806 | 912 | - | - | |
Phac2g01741 | 1131 | MobiDBLite | consensus disorder prediction | 796 | 817 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Phac2g01741 | Phac-Chr2 | 19413788 | 19418667 | Dispersed/Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Phac2g01741 | 3 | 1131 | Receptor kinase-like Gene Family | AT4G36180 | 68.190 | 0.0 | 1479 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-VII-3 | Phac2g01741 | Pkinase | 1e-32 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Phac2g01741 | - | - | gmx:100795838 | 1912.12 |